Mike Miliard

The company will use the funds to deliver AI-powered operational improvements to senior living communities.  

The grant will help Verily generate a detailed molecular dataset of Parkinson’s disease, integrating genomic, metabolic, immunologic and digital health data.

It is now preparing to undergo the Stage 7 EMRAM validation.

Also, the South Korean government has launched tariff support for medical device companies following Trump's tariffs.

Also, TruScreen has secured a new distribution deal to reenter India.

The technology it's using to reach patients has not only improved clinical outcomes but is also providing tangible financial benefits, while ensuring patients can easily access the care they need.

The company will use the funds to develop a miniaturized MRI scanner and build a prototype for hospital deployment.  

The companies will integrate Sonde's voice-based health monitoring technology with Saaya's mental health platform to support large enterprises with blue-collar workers.

The Los Angeles-based health system is looking to build and scale personalized medicine, specialty care, hospital workflow and clinical decision support systems using artificial intelligence.

It joins Lunit and Us2.ai in the vendor-neutral, cloud-based marketplace of medical AI solutions.